Cancer's molecular sweet tooth and the Warburg effect

被引：960

作者：

Kim, Jung-whan

Dang, Chi V.

机构：

[1] Johns Hopkins Univ, Sch Med, Div Hematol, Dept Med, Baltimore, MD USA

[2] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr John Hopkins, Baltimore, MD USA

来源：

CANCER RESEARCH | 2006年 / 66卷 / 18期

关键词：

D O I：

10.1158/0008-5472.CAN-06-1501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

More than 80 years ago, the renowned biochemist Otto Warburg described how cancer cells avidly consume glucose and produce lactic acid under aerobic conditions. Recent studies arguing that cancer cells benefit from this phenomenon, termed the Warburg effect, have renewed discussions about its exact role as cause, correlate, or facilitator of cancer. Molecular advances in this area may reveal tactics to exploit the cancer cell's "sweet tooth" for cancer therapy.

引用

页码：8927 / 8930

页数：4

共 20 条

[11] Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis
Li, F
Wang, YY
Zeller, KI
Potter, JJ
Wonsey, DR
O'Donnell, KA
Kim, JW
Yustein, JT
Lee, LA
Dang, CV
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (14) : 6225 - 6234
[12] p53 regulates mitochondrial respiration
Matoba, Satoaki
Kang, Ju-Gyeong
Patino, Willmar D.
Wragg, Andrew
Boehm, Manfred
Gavrilova, Oksana
Hurley, Paula J.
Bunz, Fred
Hwang, Paul M.
[J]. SCIENCE, 2006, 312 (5780) : 1650 - 1653
[13] HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I
Cairns, RA
Fontana, L
Lim, AL
Denko, NC
[J]. CELL METABOLISM, 2006, 3 (03) : 187 - 197
[14] Akt-dependent transformation: there is more to growth than just surviving
Plas, DR
Thompson, CB
[J]. ONCOGENE, 2005, 24 (50) : 7435 - 7442
[15] Powers JT, 2004, MOL CANCER RES, V2, P203
[16] Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
Rarnanathan, A
Wang, C
Schreiber, SL
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) : 5992 - 5997
[17] Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, MA
Armour, SM
MacKenzie, ED
Boulahbel, H
Watson, DG
Mansfield, KD
Pan, Y
Simon, MC
Thompson, CB
Gottlieb, E
[J]. CANCER CELL, 2005, 7 (01) : 77 - 85
[18] Targeting HIF-1 for cancer therapy
Semenza, GL
[J]. NATURE REVIEWS CANCER, 2003, 3 (10) : 721 - 732
[19] ORIGIN OF CANCER CELLS
WARBURG, O
[J]. SCIENCE, 1956, 123 (3191) : 309 - 314
[20] Xu RH, 2005, CANCER RES, V65, P613

← 1 2 →